These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 18440692

  • 21. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z, Yan F, Wang YS, Liu HY, Gou LT, Zhao XY, Lai ST, Deng HX, Li J, Ding ZY, Xiong SQ, Kan B, Mao YQ, Chen LJ, Wei YQ, Zhao X.
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [Abstract] [Full Text] [Related]

  • 22. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
    Ma L, Chen J, Wang X, Liang X, Luo Y, Zhu W, Wang T, Peng M, Li S, Jie S, Peng A, Wei Y, Chen L.
    J Med Chem; 2011 Oct 13; 54(19):6469-81. PubMed ID: 21853991
    [Abstract] [Full Text] [Related]

  • 23. Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro.
    Park EJ, Zhao YZ, Kim YH, Lee BH, Sohn DH.
    Planta Med; 2005 Jan 13; 71(1):82-4. PubMed ID: 15678380
    [Abstract] [Full Text] [Related]

  • 24. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo.
    Chang HL, Su JH, Yeh YT, Lee YC, Chen HM, Wu YC, Yuan SS.
    Cancer Lett; 2008 Aug 18; 267(1):85-95. PubMed ID: 18430509
    [Abstract] [Full Text] [Related]

  • 25. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun 18; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

  • 26. The inhibitory effect of honokiol, a natural plant product, on vestibular schwannoma cells.
    Lee JD, Lee JY, Baek BJ, Lee BD, Koh YW, Lee WS, Lee YJ, Kwon BM.
    Laryngoscope; 2012 Jan 18; 122(1):162-6. PubMed ID: 22057812
    [Abstract] [Full Text] [Related]

  • 27. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
    Scholz A, Wagner K, Welzel M, Remlinger F, Wiedenmann B, Siemeister G, Rosewicz S, Detjen KM.
    Gut; 2009 Feb 18; 58(2):261-70. PubMed ID: 18829975
    [Abstract] [Full Text] [Related]

  • 28. Anti-angiogenic and anti-tumor apoptotic activities of a topoisomerase II inhibiting agent SJ-8026.
    Yi EY, Jeong EJ, Kang DW, Joo JH, Kwon HS, Lee SH, Park SK, Chung SG, Cho EH, Kim YJ.
    Int J Oncol; 2005 Jun 18; 26(6):1613-20. PubMed ID: 15870877
    [Abstract] [Full Text] [Related]

  • 29. Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.
    Brard L, Granai CO, Swamy N.
    Gynecol Oncol; 2006 Jan 18; 100(1):116-27. PubMed ID: 16203029
    [Abstract] [Full Text] [Related]

  • 30. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol.
    Luo Y, Xu Y, Chen L, Hu J, Peng C, Xie D, Shi J, Huang W, Xu G, Peng M, Han J, Li R, Yang S, Wei Y.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4702-5. PubMed ID: 19589678
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.
    Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X.
    World J Gastroenterol; 2004 Dec 01; 10(23):3459-63. PubMed ID: 15526365
    [Abstract] [Full Text] [Related]

  • 33. Honokiol induces cell cycle arrest and apoptosis via inhibiting class I histone deacetylases in acute myeloid leukemia.
    Li HY, Ye HG, Chen CQ, Yin LH, Wu JB, He LC, Gao SM.
    J Cell Biochem; 2015 Feb 01; 116(2):287-98. PubMed ID: 25187418
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2).
    Deng J, Qian Y, Geng L, Chen J, Wang X, Xie H, Yan S, Jiang G, Zhou L, Zheng S.
    Liver Int; 2008 Dec 01; 28(10):1458-64. PubMed ID: 18507762
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.
    Vavilala DT, Ponnaluri VK, Kanjilal D, Mukherji M.
    PLoS One; 2014 Dec 01; 9(11):e113717. PubMed ID: 25422886
    [Abstract] [Full Text] [Related]

  • 37. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK, Meeran SM, Katiyar N, Akhtar S.
    Mol Carcinog; 2009 Jan 01; 48(1):24-37. PubMed ID: 18459128
    [Abstract] [Full Text] [Related]

  • 38. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K, Dahlem C, Menger MD, Schilling MK, Kollmar O.
    Ann Surg Oncol; 2009 Sep 01; 16(9):2629-37. PubMed ID: 19551445
    [Abstract] [Full Text] [Related]

  • 39. Effects of honokiol and magnolol on acute and inflammatory pain models in mice.
    Lin YR, Chen HH, Ko CH, Chan MH.
    Life Sci; 2007 Sep 08; 81(13):1071-8. PubMed ID: 17826802
    [Abstract] [Full Text] [Related]

  • 40. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
    Chintalapati M, Truax R, Stout R, Portier R, Losso JN.
    J Agric Food Chem; 2009 Jun 24; 57(12):5201-10. PubMed ID: 19476359
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.